Rébora Karine, Laloo Benoît, Daignan-Fornier Bertrand
Institut de Biochimie et Génétique Cellulaires, Université Bordeaux 2, CNRS UMR 5095, France.
Genetics. 2005 May;170(1):61-70. doi: 10.1534/genetics.104.039396. Epub 2005 Mar 2.
Because some metabolic intermediates are involved in more than one pathway, crosstalk between pathways is crucial to maintaining homeostasis. AMP and histidine biosynthesis pathways are coregulated at the transcriptional level in response to adenine availability. 5'-Phosphoribosyl-4-carboxamide-5-aminoimidazole (AICAR), a metabolic intermediate at the crossroads between these two pathways, is shown here to be critical for activation of the transcriptional response in the absence of adenine. In this study, we show that both AMP and histidine pathways significantly contribute to AICAR synthesis. Furthermore, we show that upregulation of the histidine pathway clearly interferes with regulation of the AMP pathway, thus providing an explanation for the regulatory crosstalk between these pathways. Finally, we revisit the histidine auxotrophy of ade3 or ade16 ade17 mutants. Interestingly, overexpression of PMU1, encoding a potential phosphomutase, partially suppresses the histidine requirement of an ade3 ade16 ade17 triple mutant, most probably by reducing the level of AICAR in this mutant. Together our data clearly establish that AICAR is not just a metabolic intermediate but also acts as a true regulatory molecule.
由于一些代谢中间体参与不止一条途径,因此途径间的相互作用对于维持体内平衡至关重要。AMP和组氨酸生物合成途径在转录水平上受到共同调节,以响应腺嘌呤的可用性。5'-磷酸核糖基-4-羧酰胺-5-氨基咪唑(AICAR)是这两条途径交汇点处的一种代谢中间体,本文显示它在缺乏腺嘌呤时对转录反应的激活至关重要。在本研究中,我们表明AMP和组氨酸途径都对AICAR的合成有显著贡献。此外,我们表明组氨酸途径的上调明显干扰了AMP途径的调节,从而为这些途径之间的调节相互作用提供了解释。最后,我们重新审视了ade3或ade16 ade17突变体的组氨酸营养缺陷型。有趣的是,编码一种潜在磷酸变位酶的PMU1的过表达部分抑制了ade3 ade16 ade17三重突变体对组氨酸的需求,最有可能是通过降低该突变体中AICAR的水平。我们的数据共同明确表明,AICAR不仅是一种代谢中间体,而且还作为一种真正的调节分子发挥作用。